Recruiting at 1 site No phase Prediabetes

Prediabetes study: Bottarga vs Comparator

Official title Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food

ClinicalTrials.gov ID: NCT06988462

What this study is testing

What it's testing
The study wants to see if eating bottarga can improve blood fats, inflammation and insulin resistance compared with a similar‑calorie dairy food.
Who it's for
Adults who have diabetes, pre‑diabetes, high cholesterol, high triglycerides, low “good” HDL cholesterol, or are overweight/obese.
What's involved
Participants will take a daily dose of bottarga for 8 weeks, then switch to a calorie‑matched dairy product after a 2‑week washout. Blood draws and health checks are done before and after each period.
Time commitment
The trial lasts about 10 weeks total, with clinic visits at the start, after the first 8‑week period, after the washout, and at the end.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 60

You may be able to join if

  • Adults aged 18-60 years
  • Residents of Massachusetts
  • Presence of at least one metabolic abnormality (low HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, obesity, or HbA1c ≥ 5.7%) or a...
  • Not pregnant
  • Willing to consume a nutritional supplement and comply with study procedures

You likely can't join if

  • Use of any medications for diabetes (except metformin), dyslipidemia (except statins), or immunosuppression
  • Current use of any supplements containing n-3 fatty acids
  • Current use of illicit drugs (other than marijuana)
  • Use of hormone therapy (except oral contraceptives)
  • Known allergies to fish, seafood, or any fish-derived products, including bottarga
  • Pregnancy
See the full eligibility criteria
Who can join
  • Adults aged 18-60 years
  • Residents of Massachusetts
  • Presence of at least one metabolic abnormality (low HDL cholesterol, elevated LDL cholesterol, elevated triglycerides, obesity, or HbA1c ≥ 5.7%) or a diagnosis of diabetes
  • Not pregnant
  • Willing to consume a nutritional supplement and comply with study procedures
What rules you out
  • Use of any medications for diabetes (except metformin), dyslipidemia (except statins), or immunosuppression
  • Current use of any supplements containing n-3 fatty acids
  • Current use of illicit drugs (other than marijuana)
  • Use of hormone therapy (except oral contraceptives)
  • Known allergies to fish, seafood, or any fish-derived products, including bottarga
  • Pregnancy
  • Clinical evidence or history of hepatic or renal insufficiency
  • Immunodeficiency conditions
  • History of non-skin cancer
  • Participation in other clinical research studies

The study team makes the final eligibility decision.

Where it is enrolling

  • Sommerville, Massachusetts, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Sommerville, Massachusetts, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.